Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
نویسندگان
چکیده
PURPOSE The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease. METHODS We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology. RESULTS We found increased cDNA levels in NSCLC patients compared to control individuals. We also found a decreased overall survival time in patients presenting high cDNA levels, when compared to lower cDNA concentrations. CONCLUSIONS Quantification of cDNA may be a good tool for NSCLC detection with potential for clinical applicability.
منابع مشابه
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
BACKGROUND Circulating DNA is observed at higher concentrations in patients with lung cancer than in controls. Qualitative and quantitative analysis of circulating DNA is a promising noninvasive tool. Our aim was to prospectively study the association between the catalytic subunit of telomerase (human telomerase reverse transcriptase [hTERT]) in plasma and clinical variables and survival in a l...
متن کاملCirculating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
Circulating cell-free DNA (cfDNA), which can be obtained from plasma or serum by non-invasive procedures, has showed great potential to predict treatment response and survival for cancer patients. Several studies have assessed the prognostic and predictive value of cfDNA in non-small cell lung cancer (NSCLC). However, these studies were often small and reported varying results. To address this ...
متن کاملTenascin-C serum levels and its prognostic power in non-small cell lung cancer
BACKGROUND Tenascin-C is overexpressed in the stroma of most solid malignancies and may function as a diagnostic tumor marker. This study was conducted to evaluate the potential significance of Tenascin-C as a predictive marker for tumor progression in the sera of non-small cell lung cancer (NSCLC) patients. RESULTS Serum concentration of Tenascin-C is significantly elevated in NSCLC patients...
متن کاملCirculating free DNA, new dynamic marker in nonsmall cell lung cancer patients?
Platinum-based doublet chemotherapy prolongs survival and improves quality of life as first-line treatment for non-selected and good performance status patients with advanced nonsmall cell lung cancer (NSCLC) [1]. However, the survival benefit is limited, even if this combination is the standard of care for decades, no clinically relevant predictive biomarkers have been discovered so far. The i...
متن کاملCirculating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
Cell-free DNA (cfDNA) and circulating tumor cells (CTCs) are promising prognostic and predictive biomarkers in non-small cell lung cancer (NSCLC). In this study, we examined the prognostic role of cfDNA and CTCs, in separate and joint analyses, in NSCLC patients receiving first line chemotherapy. Seventy-three patients with advanced NSCLC were enrolled in this study. CfDNA and CTC were analyzed...
متن کامل